These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24685743)

  • 1. The protective effect of HIV-2 infection: implications for understanding HIV-1 immunity.
    Kanki PJ; Rowland-Jones S
    AIDS; 2014 Apr; 28(7):1065-7. PubMed ID: 24685743
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of HIV-2 infection on HIV-1 disease progression and mortality.
    Esbjörnsson J; Månsson F; Kvist A; Isberg PE; Nowroozalizadeh S; Biague AJ; da Silva ZJ; Jansson M; Fenyö EM; Norrgren H; Medstrand P
    AIDS; 2014 Feb; 28(4):614-5. PubMed ID: 24469002
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of HIV-2 infection on HIV-1 disease progression and mortality: reply.
    Matser A; Van Tienen C; Schim Van Der Loeff MF
    AIDS; 2014 Feb; 28(4):615-7. PubMed ID: 24469003
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals.
    Esbjörnsson J; Månsson F; Kvist A; Isberg PE; Biague AJ; da Silva ZJ; Jansson M; Fenyö EM; Norrgren H; Medstrand P
    AIDS; 2014 Apr; 28(7):949-57. PubMed ID: 24812673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality rates in people dually infected with HIV-1/2 and those infected with either HIV-1 or HIV-2: a systematic review and meta-analysis.
    Prince PD; Matser A; van Tienen C; Whittle HC; Schim van der Loeff MF
    AIDS; 2014 Feb; 28(4):549-58. PubMed ID: 23921613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical care versus ethical obligations: HIV-1 and -2 co-infection with hepatitis B in a pregnant Jehovah's Witness.
    Quinn KJ; McCarty EJ; Dinsmore WM; Quah SP
    Int J STD AIDS; 2012 Jul; 23(7):e5-6. PubMed ID: 22844019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009.
    Heitzinger K; Sow PS; Dia Badiane NM; Gottlieb GS; N'Doye I; Toure M; Kiviat NB; Hawes SE;
    Int J STD AIDS; 2012 Oct; 23(10):710-6. PubMed ID: 23104745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No observed effect of GB virus C coinfection on disease progression in a cohort of African woman infected with HIV-1 or HIV-2.
    Kaye S; Howard M; Alabi A; Hansmann A; Whittle H; Schim van der Loeff M
    Clin Infect Dis; 2005 Mar; 40(6):876-8. PubMed ID: 15736023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual HIV-1 and HIV-2 infection in a West African infant.
    van der Sande MA; Luong TN; Schim van der Loeff MF; Sabally S; Aveika AA; Corrah T; Sarge-Njie R; Kaye S; Whittle HC
    Ann Trop Paediatr; 2004 Sep; 24(3):277-8. PubMed ID: 15479581
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV-2 infection and HIV-1/HIV-2 dual reactivity in patients with and without AIDS-related symptoms in Gabon.
    Tevi-Benissan C; Okome M; Makuwa M; Nkoume MN; Lansoud-Soukate J; Georges A; Georges-Courbot MC; Belec L
    Emerg Infect Dis; 1998; 4(1):130-1. PubMed ID: 9452410
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain.
    Requena S; Caballero E; Lozano AB; Ríos-Villegas MJ; Benito R; Rojo S; Cabezas T; Macià MD; Nieto MDC; Soriano V; de Mendoza C;
    AIDS; 2019 Nov; 33(14):2167-2172. PubMed ID: 31373918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant differences in DNA viral load between HIV-1 and HIV-2 infected patients.
    Gueudin M; Bénard A; Chêne G; Matheron S; Simon F
    AIDS; 2008 Jul; 22(12):1519-20. PubMed ID: 18614877
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment on Gautheret-Dejean et al.: Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.
    Hønge BL; Jespersen S; Mendes DV; Wejse C; Erikstrup C
    J Med Virol; 2016 Mar; 88(3):367-8. PubMed ID: 26366875
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention.
    Bruhn CA; Gilbert MT
    Lancet Infect Dis; 2011 Apr; 11(4):260-1. PubMed ID: 21453865
    [No Abstract]   [Full Text] [Related]  

  • 15. [New aspects of the pathogenesis of HIV infections].
    Rubbert A
    Zentralbl Gynakol; 1999; 121(11):543-5. PubMed ID: 10612223
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in proviral DNA load between HIV-1-infected and HIV-2-infected patients.
    Gottlieb GS; Hawes SE; Kiviat NB; Sow PS
    AIDS; 2008 Jul; 22(11):1379-80. PubMed ID: 18580622
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards a better understanding of the epidemiology of HIV-2.
    Schim van der Loeff MF; Aaby P
    AIDS; 1999; 13 Suppl A():S69-84. PubMed ID: 10885765
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnosis of HIV-1/2 dual infection using dilution analysis of type-specific antibody.
    Ariyoshi K; Cham F; Berry N; Harding E; Sabally S; N'Gom PT; Ishikawa K; Corrah T; Tedder R; Whittle H
    AIDS; 1998 Dec; 12(18):2504-5. PubMed ID: 9875593
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of routine molecular testing and prevalence of HIV-2 infection in regions hardest-hit by HIV infection.
    Forbi JC; Esona MD; Iperepolu HO; Adoga MP; Agwale SM
    J Infect Dev Ctries; 2012 Dec; 6(12):854-9. PubMed ID: 23276739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to Hønge et al.: Comment on Gautheret-Dejean et al.: Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.
    Gautheret-Dejean A; Bocobza J; Brunet S; Damond F; Plantier JC; Barin F
    J Med Virol; 2016 Mar; 88(3):369-70. PubMed ID: 26399874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.